Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Early Responses At 3 Months and 12 Months After Starting Imatinib As Predictive Factors For The Achievement Of Deep MR In Japanese CML Patients

Masayoshi Masuko, MD, PhD, Tatsuo Furukawa, MD, PhD, Tadashi Koike, MD, Kazue Takai, MD, Koichi Nagai, MD, Kenji Kishi, MD, PhD, Yoshinobu Seki, MD, Hoyu Takahashi, MD, PhD, Sadao Aoki, MD, PhD, Takashi Kozakai, MD, Yasuhiko Shibasaki, MD, Takashi Ushiki, MD, Ken Toba, MD, PhD, Miwako Narita, MD, PhD, Masuhiro Takahashi, MD, PhD, Hirohito Sone, MD, PhD, Akira Shibata, MD

Blood (2013) 122 (21): 2744.

https://doi.org/10.1182/blood.V122.21.2744.2744

Published: 2013

Journal Articles

Apoptosis of Leukemic Cells by Using tRNase Z L Under the Direction of Oncogene-Targeting Small Guide RNA.

Norihiro Watanabe, Miwako Narita, MD, Akie Yamahira, Tomoyo Taniguchi, Tatsuo Furukawa, MD, Tetsuo Yoshida, Tatsuya Miyazawa, Masayuki Nashimoto, Masuhiro Takahashi, MD

Blood (2010) 116 (21): 3763.

https://doi.org/10.1182/blood.V116.21.3763.3763

Published: 2010

Journal Articles

Essential Role of γδT Cells In Naturally Acquired Immunity to Falciparum Malaria

Tomoyo Kanda-Taniguchi, PhD, Kaiissar Md. Mannoor, PhD, Changchun Li, MD, PhD, Norihiro Watanabe, PhD, Akie Yamahira, Samlane Phompida, Miwako Narita, MD, PhD, Hisami Watanabe, PhD, Masuhiro Takahashi, MD

Blood (2010) 116 (21): 4877.

https://doi.org/10.1182/blood.V116.21.4877.4877

Published: 2010

Journal Articles

Tumor Antigen Small Guide (sg) RNA as a Completely Unique Nucleic Acid Medicine for Leukemia and Other Tumors.

Norihiro Watanabe, Miwako Narita, MD, Akie Yamahira, Nozomi Tochiki, Takeshi Nakamura, Anri Saitoh, Masami Kaji, Tomoyo Taniguchi, Tatsuo Furukawa, MD, Yoshifusa Aizawa, MD, Masayuki Nashimoto, Masuhiro Takahashi, MD

Blood (2009) 114 (22): 2461.

https://doi.org/10.1182/blood.V114.22.2461.2461

Published: 2009

Journal Articles

Effectiveness of WT1 Peptide Vaccination Combined with Imatinib in a Patient with CML in Chronic Phase.

Anri Saitoh, Miwako Narita, MD, Akie Yamahira, Takeshi Nakamura, Nozomi Tochiki, Norihiro Watanabe, Masami Kaji, Tomoyo Taniguchi, Masayoshi Masuko, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Ichiro Fuse, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2009) 114 (22): 4253.

https://doi.org/10.1182/blood.V114.22.4253.4253

Published: 2009

Journal Articles

A Unique Immunotherapeutic Atrategy by Using a Leukemic Plasmacytoid Dendritic Cell Line (PMDC05) as Potent Antigen Presenting Cells.

Takeshi Nakamura, Miwako Narita, MD, Akie Yamahira, Norihiro Watanabe, Nozomi Tochiki, Anri Saitoh, Masami Kaji, Tomoyo Taniguchi, Shigeo Hashimoto, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Ichiro Fuse, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2009) 114 (22): 5117.

https://doi.org/10.1182/blood.V114.22.5117.5117

Published: 2009

Journal Articles

Induction of Recipient Cell-Specific Donor T Cell Anergy by UV-C-Irradiated Recipient Immature Monocyte-Derived Dendritic Cells.

Nozomi Tochiki, Miwako Narita, MD, Zhiyin Zheng, MD, Chengfang Lu, MD, Norihiro Watanabe, Anri Saitoh, Noriyuki Satoh, Tatsuo Furukawa, MD, Ken Toba, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2007) 110 (11): 4897.

https://doi.org/10.1182/blood.V110.11.4897.4897

Published: 2007

Journal Articles

Anti-Tumor Cytotoxicity of γδ T Cells Expanded from Blood Cells of Myeloma and Leukemia Patients Against Self Tumor Cells — Enhancement of the Anti-Tumor Cytotoxicity by Type I IFN, Dendritic Cells, and Activated αβ T Cells.

Anri Saito, Miwako Narita, MD, Norihiro Watanabe, Nozomi Tochiki, Noriyuki Satoh, Toshio Yano, MD, Jun Takizawa, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2007) 110 (11): 4762.

https://doi.org/10.1182/blood.V110.11.4762.4762

Published: 2007

Journal Articles

In Vitro Expansion of Blood γδ T Cells in Patients with Myeloma/Lymphoma and Anti-Tumor Cytotoxicity of the Expanded γδ T Cells.

Anri Saito, Miwako Narita, MD, Norihiro Watanabe, Nozomi Tochiki, Yumi Hiroi, Takayoshi Shirasaki, Jun Takizawa, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Sadao Aoki, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2006) 108 (11): 3895.

https://doi.org/10.1182/blood.V108.11.3895.3895

Published: 2006

Journal Articles

Human Plasmacytoid Dendritic Cell like Leukemia Cell Line (PMDC05) Established from a Patient with CD4 + CD56 + Acute Leukemia.

Miwako Narita, MD, Nozomi Tochiki, Norihiro Watanabe, Anri Saitoh, Shigeo Hashimoto, MD, Junjiro Tsuchiyama, MD, Tatsuo Furukawa, MD, Sadao Aoki, MD, Ichiro Fuse, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2006) 108 (11): 4456.

https://doi.org/10.1182/blood.V108.11.4456.4456

Published: 2006

Journal Articles

Human Plasmacytoid Dendritic Cell Line (PMDC05) Established from a Patient with CD4 + CD56 + Acute Leukemia.

Miwako Narita, MD, Nozomi Tochiki, Shigeo Hashimoto, MD, Asuka Sekiguchi, Norihiro Watanabe, Ayumi Yokoyama, Anri Saitoh, Junjiro Tsuchiyama, MD, Toshio Yano, MD, Masayoshi Masuko, MD, Ken Toba, MD, Tatsuo Furukawa, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2005) 106 (11): 4330.

https://doi.org/10.1182/blood.V106.11.4330.4330

Published: 2005

Journal Articles

Both Functions of Antigen Uptake/Presentation and Anti-Tumor Cytotoxicity Are Possessed by Human Blood γδ T Cells.

Norihiro Watanabe, Miwako Narita, MD, Ayumi Yokoyama, Asuka Sekiguchi, Anri Saito, Nozomi Tochiki, Jun Takizawa, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2005) 106 (11): 2383.

https://doi.org/10.1182/blood.V106.11.2383.2383

Published: 2005

Journal Articles

Anti-Tumor Cytotoxicity of Blood γδ T Cells Expanded from Leukemia Patients Against Autologous Leukemia Cells—Enhancement of the Anti-Tumor Cytotoxicity by Type I IFN.

Anri Saito, Miwako Narita, MD, Norihiro Watanabe, Ayumi Yokoyama, Asuka Sekiguchi, Nozomi Tochiki, Louie Alldawi, MD, Jun Takizawa, MD, Shigeo Hashimoto, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2005) 106 (11): 2385.

https://doi.org/10.1182/blood.V106.11.2385.2385

Published: 2005

Journal Articles

Bestowing Transient Cytotoxic Capability on Dendritic Cells by Transfection with In Vitro Transcribed (IVT) TRAIL mRNA.

Norihiro Watanabe, Miwako Narita, MD, Toshio Yano, MD, Naoko Sato, MD, Asuka Sekiguchi, Anri Saito, Ayumi Yokoyama, Flavio Ayres, PhD, Louie Alldawi, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Yoko Watanabe, Yoshiaki Takahashi, PhD, Masuhiro Takahashi, MD

Blood (2004) 104 (11): 5282.

https://doi.org/10.1182/blood.V104.11.5282.5282

Published: 2004

Journal Articles

Enhancing Effects of Heparin/Low Molecular Weight Heparin/Heparan Sulfate on Antigen Presentation and Antigen-Specific Cytotoxic T Lymphocyte (CTL) Induction by Monocyte-Derived Dendritic Cells.

Asuka Sekiguchi, Miwako Narita, MD, Toshio Yano, MD, Naoko Sato, MD, Anri Saito, Norihiro Watanabe, Ayumi Yokoyama, Flavio Ayres, PhD, Louie Alldawi, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Yoko Watanabe, Yoshiaki Takahashi, PhD, Masuhiro Takahashi, MD

Blood (2004) 104 (11): 3816.

https://doi.org/10.1182/blood.V104.11.3816.3816

Published: 2004

Journal Articles

Generation of Antigen Specific Cytotoxic T Lymphocytes (CTL) by Dendritic Cells (DCs) Transfected with In Vitro Transcribed (IVT) SART-1 and WT-1 mRNA.

Anri Saito, Miwako Narita, MD, Toshio Yano, MD, Naoko Sato, MD, Asuka Sekiguchi, Norihiro Watanabe, Ayumi Yokoyama, Flavio Ayres, PhD, Louie Alldawi, Tatsuo Furukawa, MD, Ken Toba, MD, Yoko Watanabe, Yoshiaki Takahashi, PhD, Masuhiro Takahashi, MD

Blood (2004) 104 (11): 3859.

https://doi.org/10.1182/blood.V104.11.3859.3859

Published: 2004

NARROW

Early Responses At 3 Months and 12 Months After Starting Imatinib As Predictive Factors For The Achievement Of Deep MR In Japanese CML Patients

Apoptosis of Leukemic Cells by Using tRNase Z L Under the Direction of Oncogene-Targeting Small Guide RNA.

Essential Role of γδT Cells In Naturally Acquired Immunity to Falciparum Malaria

Tumor Antigen Small Guide (sg) RNA as a Completely Unique Nucleic Acid Medicine for Leukemia and Other Tumors.

Effectiveness of WT1 Peptide Vaccination Combined with Imatinib in a Patient with CML in Chronic Phase.

A Unique Immunotherapeutic Atrategy by Using a Leukemic Plasmacytoid Dendritic Cell Line (PMDC05) as Potent Antigen Presenting Cells.

Induction of Recipient Cell-Specific Donor T Cell Anergy by UV-C-Irradiated Recipient Immature Monocyte-Derived Dendritic Cells.

Anti-Tumor Cytotoxicity of γδ T Cells Expanded from Blood Cells of Myeloma and Leukemia Patients Against Self Tumor Cells — Enhancement of the Anti-Tumor Cytotoxicity by Type I IFN, Dendritic Cells, and Activated αβ T Cells.

In Vitro Expansion of Blood γδ T Cells in Patients with Myeloma/Lymphoma and Anti-Tumor Cytotoxicity of the Expanded γδ T Cells.

Human Plasmacytoid Dendritic Cell like Leukemia Cell Line (PMDC05) Established from a Patient with CD4 + CD56 + Acute Leukemia.

Human Plasmacytoid Dendritic Cell Line (PMDC05) Established from a Patient with CD4 + CD56 + Acute Leukemia.

Both Functions of Antigen Uptake/Presentation and Anti-Tumor Cytotoxicity Are Possessed by Human Blood γδ T Cells.

Anti-Tumor Cytotoxicity of Blood γδ T Cells Expanded from Leukemia Patients Against Autologous Leukemia Cells—Enhancement of the Anti-Tumor Cytotoxicity by Type I IFN.

Bestowing Transient Cytotoxic Capability on Dendritic Cells by Transfection with In Vitro Transcribed (IVT) TRAIL mRNA.

Enhancing Effects of Heparin/Low Molecular Weight Heparin/Heparan Sulfate on Antigen Presentation and Antigen-Specific Cytotoxic T Lymphocyte (CTL) Induction by Monocyte-Derived Dendritic Cells.

Generation of Antigen Specific Cytotoxic T Lymphocytes (CTL) by Dendritic Cells (DCs) Transfected with In Vitro Transcribed (IVT) SART-1 and WT-1 mRNA.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only